北美特发性肺纤维化患者中抗中性粒细胞胞浆抗体的患病率与临床意义
该回顾性研究在加州大学旧金山分校(发现队列)和芝加哥大学(复制队列)两个独立IPF队列中检测MPO和PR3-ANCA,发现ANCA阳性率分别为4.0%和5.1%,ANCA阳性与基线疾病严重程度及无移植生存无显著关联,但部分MPO阳性患者发展为血管炎。
要点
- IPF患者中ANCA阳性率约4.0%–5.1%,并不常见。
- MPO-ANCA阳性IPF患者中部分(33%和25%)发生临床血管炎,PR3阳性者无血管炎发生。
核心结论
- 在北美IPF患者中ANCA阳性不常见,且与基线疾病严重程度或无移植生存无关;但相当比例的MPO-ANCA阳性IPF患者会发生临床血管炎。
研究设计与样本
- 回顾性研究,纳入加州大学旧金山分校(发现队列)和芝加哥大学(复制队列)两个独立IPF队列,所有患者检测MPO-ANCA和PR3-ANCA。
主要发现
- 发现队列353例IPF患者中14例(4.0%;95%CI 2.2-6.5)ANCA阳性,复制队列392例中20例(5.1%;95%CI 3.1-7.8)阳性。
- MPO抗体阳性者中,发现队列6例有2例(33%)、复制队列12例有3例(25%)发生血管炎;PR3阳性者无血管炎发生。
- ANCA阳性患者较阴性者更可能为女性,且CT上更可能有一些磨玻璃影。
临床怎么用
- 对IPF患者检测ANCA有助于识别可能发展为血管炎(特别是MPO-ANCA阳性)的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCAs) have been reported to occur in 7% to 10% of patients with idiopathic pulmonary fibrosis (IPF), but their clinical relevance remains unclear. The aim of this study was to estimate the prevalence of ANCAs in a North American population with IPF and evaluate their clinical significance. METHODS: This was a retrospective study of two independent cohorts of patients diagnosed with IPF at the University of California San Francisco (discovery cohort) and the University of Chicago (replication cohort). Myeloperoxidase (MPO) and proteinase 3 (PR3) ANCAs were measured in all patients. Prevalence and associations of ANCAs with clinical characteristics and transplant-free survival were evaluated. RESULTS: A total of 14 of 353 (4.0%; 95% CI, 2.2-6.5) and 20 of 392 (5.1%; 95% CI, 3.1-7.8) patients with IPF were positive for ANCAs at the time of diagnosis in the discovery and replication cohorts, respectively. Among those positive for MPO antibodies, two of six (33%) in the discovery cohort and three of 12 (25%) in the replication cohort developed vasculitis. None of the patients who were PR3-positive developed vasculitis. Patients who were ANCA-positive were more likely to be women than patients who were ANCA-negative, and were more likely to have some ground-glass opacities on CT scan. In the combined cohort of 745 patients, median transplant-free survival was not significantly different in patients who were ANCA-positive vs ANCA-negative (P = .57). CONCLUSIONS: ANCA positivity is uncommon in North American patients with IPF and not associated with baseline disease severity or transplant-free survival; however, a significant proportion of patients who are MPO-positive with IPF develop clinical vasculitis.
引用
- Liu GY, Ventura IB, Achtar-Zadeh N, et al. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019. PMID: 31181198. doi:10.1016/j.chest.2019.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。